Sharing successes, challenges and daily happenings in the Department of Medicine
We are thrilled to announce that Matthew Lautzenheiser, MHA, will serve as Chief Administrative Officer for the Department of Medicine at the Johns Hopkins University… Read More »Lautzenheiser Named Chief Administrative Officer
The Early Career Cohort Leadership Program (ECCLP) by the Office of Faculty – Women in Science and Medicine is designed to support the professional advancement… Read More »Early Career Cohort Leadership Program
ARTICLE: Discharging Patients Against Medical Advice AUTHORS: Clement D Lee, Michelle M Mello, Owen Bradfield, Mary Catherine Beach JOURNAL: N Engl J Med. 2023 Mar 30;388(13):1230-1232. doi: 10.1056/NEJMclde2210118. Case Vignette… Read More »Discharging Patients Against Medical Advice
ARTICLE: US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy AUTHORS: Sonya Krishnan, Richard E Chaisson JOURNAL: Clin Infect Dis. 2024 Mar 20;78(3):514-517. doi: 10.1093/cid/ciad659. Abstract The provision of… Read More »US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy
We celebrate National Nurses Week every year on May 6-12 in order to honor all of the remarkable nurses at Johns Hopkins and in the… Read More »Happy Nurses Week
Functional Movement Disorder (FMD) is a subtype of Functional Neurological Symptom Disorder (FNSD) with primarily motor symptoms (Espay et al. JAMA Neurol 75(9):1132-1141) Patients present to… Read More »FMD Diagnostic Clinic Opens
To join via Zoom: https://jhjhm.zoom.us/j/95253791862
JHH attending staff can request Leadership Response Team (LRT) reviews to address urgent administrative concerns related to patient care and safety, when normal resources and… Read More »JHH Leadership Response Team Reviews
ARTICLE: Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses AUTHORS: Man-Fung Yuen 1, Scott Fung 2, Xiaoli Ma 3, Tuan T Nguyen 4, Tarek Hassanein 5, Hie-Won Hann 6, Magdy Elkhashab 7, Ronald G Nahass 8, James S… Read More »Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses
The next cycle of the Open Payments Program/Sunshine Act has begun. This is the federal law that requires manufacturers of drugs, medical devices and biologics… Read More »Open Payments Sunshine Act Review and Dispute Period Now Underway